Compare IMOS & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMOS | AORT |
|---|---|---|
| Founded | 1997 | 1984 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.5M | 2.1B |
| IPO Year | N/A | 1993 |
| Metric | IMOS | AORT |
|---|---|---|
| Price | $28.69 | $47.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.36 |
| AVG Volume (30 Days) | 14.4K | ★ 376.1K |
| Earning Date | 11-11-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $748,307,671.00 | $422,646,000.00 |
| Revenue This Year | $5.78 | $15.97 |
| Revenue Next Year | $10.84 | $10.96 |
| P/E Ratio | $133.69 | ★ N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $12.78 | $21.97 |
| 52 Week High | $30.98 | $48.25 |
| Indicator | IMOS | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 57.44 | 60.45 |
| Support Level | $27.91 | $45.41 |
| Resistance Level | $29.12 | $48.25 |
| Average True Range (ATR) | 0.60 | 1.35 |
| MACD | -0.27 | 0.18 |
| Stochastic Oscillator | 40.94 | 80.97 |
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.